ELIZABETH E REED

CIK 1283303 · Chief Legal Officer and GC · last filed 2026-05-06

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$5.48M

Companies

4

Total Filings

59

Lifetime Open-Market Net

-$6.93M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
TVTX Chief Legal Officer and GC 105,211 $52.04 $5.48M -$6.42M 32 2026-05-06
Travere Therapeutics, Inc. (RTRX) Delisted SVP, GC & Corporate Secretary 25,431 -$510.1K 19 2020-11-17
Eiger BioPharmaceuticals, Inc. (CLDN) Delisted VP, General Counsel 169 $0 1 2015-01-05
ANADYS PHARMACEUTICALS INC (ANDS) Delisted SVP, Legal Affairs and GC $0 7 2011-01-24

Recent Filings · Page 2 of 6

59 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2025-02-12 TVTX Mixed -$188.2K EDGAR
2025-02-04 TVTX Mixed +12,549 -$177.1K EDGAR
2025-01-23 TVTX Sell (S) −2,437 -$47.4K EDGAR
2024-09-09 TVTX Mixed +2,363 -$50.5K EDGAR
2024-02-02 TVTX Mixed +20,236 -$41.5K EDGAR
2024-01-25 TVTX Sell (S) −2,062 -$18.5K EDGAR
2023-09-05 TVTX Mixed +1,485 -$26.7K EDGAR
2023-05-12 TVTX Sell (S) −825 -$13.7K EDGAR
2023-02-02 TVTX Mixed +17,660 -$57.6K EDGAR
2023-01-26 TVTX Sell (S) −2,062 -$44.3K EDGAR
Showing 1120 of 59
Page 2 of 6
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.